Results 71 to 80 of about 35,674 (297)
This study explores the opposing effects of the mGluR2 and mGluR3 receptors on amyloid precursor protein processing. mGluR2 promotes amyloidogenic cleavage, while mGluR3 favors non‐amyloidogenic pathways. Using a brain‐penetrant nanobody as a mGluR2 positive allosteric modulator, the study uncovers how its chronic activation aggravates amyloid‐β burden
Pierre‐André Lafon +21 more
wiley +1 more source
Buprenorphine-Containing Medications for the Treatment of Opioid Use Disorder in Primary Care
The opioid epidemic has undoubtedly become a major problem across the United States. Whether it is in primary care, emergency services, or inpatient hospitalization, every healthcare worker witnesses the effects of opioid use disorder. Pharmacotherapy is
Scherer, Shannon
core
Background Medication treatment for opioid use disorder (OUD) (MOUD; buprenorphine and methadone) reduces opioid use and overdose. Discontinuation of MOUD can quickly lead to relapse, overdose and death.
Breanne E. Biondi +4 more
doaj +1 more source
Lesion Site‐Targeted Microspheres Modulate Nav1.7‐Related Signaling for Osteoarthritis Treatment
Cartilage‐targeted carbamazepine‐loaded WYRGRL‐modified composite microspheres (CBZ/WCOM) anchor to exposed type II collagen in osteoarthritic lesions and release carbamazepine under acidic conditions. This bind‐then‐release platform modulates Nav1.7‐related sodium signaling, Na⁺/Ca²⁺ exchanger‐associated Ca2+ dynamics, and heat shock protein 70 ...
Cheng Chen +15 more
wiley +1 more source
Prescription opioid and benzodiazepine medications and occupational safety and health : information for employers and healthcare providers (2021-116) [PDF]
"Prescription opioid medications intended for pain management and prescription benzodiazepines for conditions such as anxiety or insomnia, when used alone or together, often have side effects that can affect workers' health and safety.
core +1 more source
Abstract Substance use, specifically opioid and methamphetamine use, is of increasing concern among American Indian (AI) populations in the Great Plains. This community‐driven participatory study investigated the impacts of substance use and community‐defined needs in treating addiction.
Brynn Luger +8 more
wiley +1 more source
Acceptability and feasibility of a shared decision-making tool for medication for opioid use disorder [PDF]
In 2020, over 26.8 million people around the world were affected by opioid use disorder, with approximately 2.7 million cases of opioid use disorder in the United States alone.
David, Rachel
core +1 more source
ABSTRACT Arthrogryposis Multiplex Congenita (AMC) encompasses several hundred conditions with diverse genetic, pathophysiological, and clinical origins. The overarching EXPLAIN study explores underlying causes and implications of AMC and represents the largest clinical cohort of adults with AMC reported to date.
My Vuong Hermansen +5 more
wiley +1 more source
Background Buprenorphine-naloxone is an evidence-based treatment for Opioid Use Disorder. However, despite its efficacy, nearly half of participants are unsuccessful in achieving stabilization (i.e., period of time following medication induction in which
Kirsten J. Langdon +5 more
doaj +1 more source
Objective Pathogenic variants in GNAO1 cause a spectrum of epilepsy, movement disorders, and developmental impairment. Clinical heterogeneity complicates prognosis and therapeutic development. We present the first longitudinal natural history study of GNAO1‐related disorders (GNAO1‐RD) to delineate phenotypic trajectories. Methods Sixty‐six individuals
Jana Domínguez‐Carral +52 more
wiley +1 more source

